MedPath

Predicting Adverse Pregnancy Outcomes (PAPO) Study: An observational study to determine factors in both male and female partners to predict healthy pregnancies and adverse pregnancy outcomes

Not Applicable
Recruiting
Conditions
Pregnancy Complications
Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy
Registration Number
ACTRN12609000254291
Lead Sponsor
ational Health and Medical Research Council (NHMRC)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
750
Inclusion Criteria

Recruit before 12 weeks gestation, Consent to participate

Exclusion Criteria

Serious medical illness, lack of informed consent

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pregnancy outcome data will be collected from the volunteers medical records[At the end of delivery or pregnancy loss]
Secondary Outcome Measures
NameTimeMethod
Deoxyribonucleic acid (DNA) damage levels will be measured in lymphocytes using the cytokinesis block micronucleus (CBMN) assay.[One time point before pregnancy (the couple must be actively trying to get pregnant) and at 12 weeks gestation];Blood concentrations of folate, vitamin 12, homocysteine and enzyme polymorphisms within folate metabolism. These tests will be done by SA pathology using routine laborarty tests.[One time point before pregnancy (the couple must be actively trying to get pregnant) and at 12 weeks gestation]
© Copyright 2025. All Rights Reserved by MedPath